Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Novocure Ltd (NVCR) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Novocure Ltd. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1645113.
Total stock buying since 2015: $1,955,939.
Total stock sales since 2015: $562,447,534.
Total stock option exercises since 2015: $174,081,556.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 20,000 | $231,540 | 51,153 | $1,003,641 | 0 | $0 |
| 2024 | 0 | $0 | 7,270 | $142,081 | 124,373 | $2,838,191 |
| 2023 | 0 | $0 | 355,631 | $37,028,303 | 267,623 | $2,779,194 |
| 2022 | 0 | $0 | 201,400 | $16,501,140 | 85,297 | $820,884 |
| 2021 | 4,974 | $501,095 | 305,402 | $53,648,487 | 158,778 | $9,089,465 |
| 2020 | 4,200 | $357,054 | 952,731 | $97,931,468 | 1,050,394 | $38,728,371 |
| 2019 | 0 | $0 | 4,036,171 | $248,001,465 | 4,542,155 | $101,208,755 |
| 2018 | 0 | $0 | 2,245,603 | $61,035,178 | 1,568,421 | $10,066,548 |
| 2017 | 125,000 | $866,250 | 2,555,165 | $43,935,150 | 1,573,732 | $4,510,852 |
| 2016 | 0 | $0 | 879,076 | $3,220,621 | 2,350,974 | $4,039,109 |
| 2015 | 0 | $0 | 0 | $0 | 1,100 | $187 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-05 | Benaim Ely (Chief Medical Officer) | Sale | 2,918 | 131.53 | 383,804 |
| 2021-03-04 | Leonard Frank X (Chief Development Officer) | Sale | 567 | 137.55 | 77,993 |
| 2021-03-04 | Cordova Ashley (Chief Financial Officer) | Sale | 567 | 137.55 | 77,993 |
| 2021-03-04 | Shah Pritesh (Chief Commercial Officer) | Sale | 2,658 | 137.55 | 365,618 |
| 2021-03-04 | Longsworth Todd Christopher (General Counsel) | Sale | 3,084 | 137.55 | 424,216 |
| 2021-03-04 | Benaim Ely (Chief Medical Officer) | Sale | 1,888 | 137.55 | 259,701 |
| 2021-03-04 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Sale | 3,854 | 137.55 | 530,133 |
| 2021-03-03 | Shah Pritesh (Chief Commercial Officer) | Sale | 2,174 | 150.78 | 327,795 |
| 2021-03-03 | Benaim Ely (Chief Medical Officer) | Sale | 3,475 | 150.78 | 523,960 |
| 2021-03-03 | Benaim Ely (Chief Medical Officer) | Option Ex | 3,475 | 69.37 | 241,060 |
| 2021-03-02 | Leonard Frank X (Chief Development Officer) | Sale | 430 | 152.05 | 65,382 |
| 2021-03-02 | Cordova Ashley (Chief Financial Officer) | Sale | 428 | 152.05 | 65,078 |
| 2021-03-02 | Shah Pritesh (Chief Commercial Officer) | Sale | 912 | 152.05 | 138,672 |
| 2021-03-02 | Longsworth Todd Christopher (General Counsel) | Sale | 2,355 | 152.05 | 358,084 |
| 2021-03-02 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Sale | 2,392 | 152.05 | 363,710 |
| 2021-02-27 | Leonard Frank X (Chief Development Officer) | Option Ex | 1,465 | 149.10 | 218,431 |
| 2021-02-27 | Cordova Ashley (Chief Financial Officer) | Option Ex | 1,465 | 149.10 | 218,431 |
| 2021-02-27 | Shah Pritesh (Chief Commercial Officer) | Option Ex | 3,086 | 149.10 | 460,122 |
| 2021-02-27 | Longsworth Todd Christopher (General Counsel) | Option Ex | 5,555 | 149.10 | 828,250 |
| 2021-02-27 | Danziger Asaf (Chief Executive Officer) | Option Ex | 9,259 | 149.10 | 1,380,516 |
| 2021-02-27 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Option Ex | 7,715 | 149.10 | 1,150,306 |
| 2021-02-22 | Weinberg Uri (Chief Science Officer) | Sale | 6,500 | 175.50 | 1,140,750 |
| 2021-02-22 | Weinberg Uri (Chief Science Officer) | Option Ex | 6,500 | 7.15 | 46,475 |
| 2021-01-15 | Longsworth Todd Christopher (General Counsel) | Sale | 63,814 | 173.61 | 11,078,557 |
| 2021-01-15 | Longsworth Todd Christopher (General Counsel) | Option Ex | 36,396 | 14.37 | 523,010 |
| 2020-12-21 | Benaim Ely (Chief Medical Officer) | Sale | 2,484 | 156.71 | 389,267 |
| 2020-12-21 | Benaim Ely (Chief Medical Officer) | Option Ex | 2,484 | 65.43 | 162,528 |
| 2020-12-18 | Danziger Asaf (Chief Executive Officer) | Sale | 207,910 | 160.50 | 33,370,594 |
| 2020-12-18 | Danziger Asaf (Chief Executive Officer) | Option Ex | 207,910 | 22.00 | 4,574,020 |
| 2020-12-18 | Hilleman Jeryl L | Sale | 2,500 | 166.40 | 416,000 |
| 2020-11-02 | Cordova Ashley (Chief Financial Officer) | Sale | 230 | 117.41 | 27,004 |
| 2020-10-29 | Shah Pritesh (Chief Commercial Officer) | Option Ex | 30,468 | 11.10 | 338,286 |
| 2020-09-25 | Weinberg Uri (Chief Science Officer) | Sale | 15,250 | 103.35 | 1,576,087 |
| 2020-09-25 | Weinberg Uri (Chief Science Officer) | Option Ex | 15,250 | 9.30 | 141,901 |
| 2020-09-18 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Sale | 8,262 | 109.15 | 901,813 |
| 2020-09-18 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Option Ex | 8,262 | 7.48 | 61,799 |
| 2020-09-17 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Sale | 12,500 | 108.17 | 1,352,112 |
| 2020-09-17 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Option Ex | 12,500 | 7.48 | 93,500 |
| 2020-09-16 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Sale | 22,012 | 107.62 | 2,368,931 |
| 2020-09-16 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Option Ex | 22,012 | 7.18 | 158,046 |
| 2020-09-15 | Danziger Asaf (Chief Executive Officer) | Sale | 103,000 | 99.00 | 10,197,000 |
| 2020-09-15 | Danziger Asaf (Chief Executive Officer) | Option Ex | 103,000 | 22.00 | 2,266,000 |
| 2020-09-15 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Sale | 50,868 | 102.82 | 5,230,298 |
| 2020-09-15 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Option Ex | 50,868 | 7.37 | 374,795 |
| 2020-09-15 | Leung Gabriel | Sale | 9,565 | 100.00 | 956,500 |
| 2020-09-15 | Leung Gabriel | Option Ex | 9,565 | 7.48 | 71,546 |
| 2020-09-14 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Sale | 25,000 | 98.01 | 2,450,225 |
| 2020-09-14 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Option Ex | 25,000 | 7.03 | 175,750 |
| 2020-09-14 | Leung Gabriel | Sale | 10,000 | 95.00 | 950,000 |
| 2020-09-14 | Leung Gabriel | Option Ex | 10,000 | 7.48 | 74,800 |
| 2020-09-10 | Leung Gabriel | Sale | 10,000 | 90.00 | 900,000 |
| 2020-09-10 | Leung Gabriel | Option Ex | 10,000 | 7.48 | 74,800 |
| 2020-09-09 | Shah Pritesh (Chief Commercial Officer) | Sale | 28,321 | 85.73 | 2,428,044 |
| 2020-09-09 | Leung Gabriel | Sale | 9,114 | 85.72 | 781,288 |
| 2020-09-09 | Leung Gabriel | Option Ex | 9,114 | 7.03 | 64,071 |
| 2020-09-02 | Shah Pritesh (Chief Commercial Officer) | Buy | 4,200 | 85.01 | 357,054 |
| 2020-09-02 | Leung Gabriel | Sale | 100 | 85.00 | 8,500 |
| 2020-09-02 | Leung Gabriel | Option Ex | 100 | 7.03 | 703 |
| 2020-08-04 | Shah Pritesh (Chief Commercial Officer) | Sale | 2,048 | 76.81 | 157,306 |
| 2020-08-03 | Shah Pritesh (Chief Commercial Officer) | Sale | 1,669 | 76.41 | 127,521 |
| 2020-08-03 | Benaim Ely (Chief Medical Officer) | Sale | 660 | 76.06 | 50,199 |
| 2020-07-31 | Shah Pritesh (Chief Commercial Officer) | Option Ex | 3,717 | 76.17 | 283,123 |
| 2020-07-31 | Benaim Ely (Chief Medical Officer) | Sale | 341 | 76.39 | 26,048 |
| 2020-07-31 | Doyle William F (Executive Chairman) | Sale | 896 | 76.39 | 68,443 |
| 2020-07-30 | Leung Gabriel | Sale | 7,112 | 75.00 | 533,400 |
| 2020-07-30 | Leung Gabriel | Option Ex | 7,112 | 7.03 | 49,997 |
| 2020-07-22 | Ambrogi Michael J. (Chief Operating Officer) | Sale | 42,972 | 66.64 | 2,863,439 |
| 2020-07-22 | Ambrogi Michael J. (Chief Operating Officer) | Option Ex | 42,972 | 14.69 | 631,258 |
| 2020-07-22 | Leung Gabriel | Sale | 9,500 | 66.56 | 632,348 |
| 2020-07-22 | Leung Gabriel | Option Ex | 9,500 | 7.03 | 66,785 |
| 2020-07-21 | Ambrogi Michael J. (Chief Operating Officer) | Sale | 3,321 | 65.06 | 216,080 |
| 2020-07-21 | Ambrogi Michael J. (Chief Operating Officer) | Option Ex | 3,321 | 16.30 | 54,148 |
| 2020-07-21 | Leung Gabriel | Sale | 500 | 65.07 | 32,536 |
| 2020-07-21 | Leung Gabriel | Option Ex | 500 | 7.03 | 3,515 |
| 2020-05-12 | Benaim Ely (Chief Medical Officer) | Sale | 2,595 | 64.78 | 168,104 |
| 2020-05-11 | Benaim Ely (Chief Medical Officer) | Sale | 1,611 | 63.73 | 102,665 |
| 2020-05-11 | Doyle William F (Executive Chairman) | Sale | 31,332 | 63.73 | 1,996,725 |
| 2020-05-08 | Weinberg Uri (Chief Science Officer) | Option Ex | 1,402 | 63.84 | 89,503 |
| 2020-05-08 | Benaim Ely (Chief Medical Officer) | Option Ex | 4,206 | 63.84 | 268,511 |
| 2020-05-06 | Doyle William F (Executive Chairman) | Sale | 29,881 | 64.27 | 1,920,451 |
| 2020-05-06 | Doyle William F (Executive Chairman) | Option Ex | 58,768 | 64.15 | 3,769,967 |
| 2020-05-05 | Shah Pritesh (Chief Commercial Officer) | Sale | 1,149 | 62.20 | 71,467 |
| 2020-05-05 | Doyle William F (Executive Chairman) | Sale | 30,283 | 62.47 | 1,891,718 |
| 2020-05-05 | Doyle William F (Executive Chairman) | Option Ex | 58,768 | 61.40 | 3,608,355 |
| 2020-05-04 | Shah Pritesh (Chief Commercial Officer) | Sale | 1,184 | 60.08 | 71,133 |
| 2020-05-04 | Doyle William F (Executive Chairman) | Option Ex | 58,768 | 60.48 | 3,554,288 |
| 2020-05-01 | Shah Pritesh (Chief Commercial Officer) | Option Ex | 2,333 | 65.80 | 153,511 |
| 2020-04-14 | Ambrogi Michael J. (Chief Operating Officer) | Sale | 27,519 | 71.37 | 1,964,141 |
| 2020-04-14 | Ambrogi Michael J. (Chief Operating Officer) | Option Ex | 35,745 | 7.15 | 255,576 |
| 2020-04-13 | Ambrogi Michael J. (Chief Operating Officer) | Sale | 30,981 | 69.59 | 2,156,122 |
| 2020-04-13 | Ambrogi Michael J. (Chief Operating Officer) | Option Ex | 22,755 | 7.15 | 162,698 |
| 2020-03-06 | Shah Pritesh (Chief Commercial Officer) | Sale | 6,151 | 66.90 | 411,514 |
| 2020-03-06 | Shah Pritesh (Chief Commercial Officer) | Option Ex | 17,500 | 7.48 | 130,900 |
| 2020-03-06 | Longsworth Todd Christopher (General Counsel) | Sale | 2,499 | 69.53 | 173,765 |
| 2020-03-06 | Ambrogi Michael J. (Chief Operating Officer) | Sale | 2,274 | 69.53 | 158,120 |
| 2020-03-06 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Sale | 3,123 | 69.53 | 217,154 |
| 2020-03-06 | Doyle William F (Executive Chairman) | Sale | 4,320 | 69.53 | 300,386 |
| 2020-03-02 | Shah Pritesh (Chief Commercial Officer) | Sale | 1,485 | 72.97 | 108,360 |
| 2020-02-28 | Shah Pritesh (Chief Commercial Officer) | Sale | 1,601 | 72.22 | 115,616 |
| 2020-02-28 | Longsworth Todd Christopher (General Counsel) | Sale | 2,643 | 72.22 | 190,864 |
| 2020-02-28 | Ambrogi Michael J. (Chief Operating Officer) | Sale | 2,673 | 72.22 | 193,030 |
| 2020-02-28 | Groenhuysen Wilhelmus Cm (Chief Operating Officer) | Sale | 3,670 | 72.22 | 265,029 |
| 2020-02-28 | Doyle William F (Executive Chairman) | Sale | 3,893 | 72.22 | 281,132 |
| 2020-02-27 | Shah Pritesh (Chief Commercial Officer) | Option Ex | 3,086 | 79.45 | 245,182 |
| 2020-02-27 | Longsworth Todd Christopher (General Counsel) | Option Ex | 5,556 | 79.45 | 441,424 |
| 2020-02-27 | Danziger Asaf (Chief Executive Officer) | Option Ex | 9,259 | 79.45 | 735,627 |
| 2020-02-27 | Ambrogi Michael J. (Chief Operating Officer) | Option Ex | 6,173 | 79.45 | 490,444 |
| 2020-02-27 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Option Ex | 7,716 | .00 | 0 |
| 2020-02-27 | Doyle William F (Executive Chairman) | Option Ex | 9,259 | 79.45 | 735,627 |
| 2020-02-25 | Longsworth Todd Christopher (General Counsel) | Sale | 8,482 | 81.16 | 688,365 |
| 2020-02-25 | Ambrogi Michael J. (Chief Operating Officer) | Sale | 11,647 | 81.16 | 945,223 |
| 2020-02-25 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Sale | 18,908 | 81.16 | 1,534,497 |
| 2020-02-24 | Shah Pritesh (Chief Commercial Officer) | Option Ex | 12,999 | 88.26 | 1,147,291 |
| 2020-02-24 | Longsworth Todd Christopher (General Counsel) | Option Ex | 21,666 | 88.26 | 1,912,241 |
| 2020-02-24 | Danziger Asaf (Chief Executive Officer) | Option Ex | 53,333 | 88.26 | 4,707,170 |
| 2020-02-24 | Ambrogi Michael J. (Chief Operating Officer) | Option Ex | 31,199 | 88.26 | 2,753,623 |
| 2020-02-24 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Option Ex | 43,333 | 88.26 | 3,824,570 |
| 2020-01-22 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Sale | 2,915 | 98.14 | 286,089 |
| 2020-01-22 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Option Ex | 2,915 | 7.03 | 20,492 |
| 2020-01-17 | Doyle William F (Executive Chairman) | Sale | 133,777 | 95.00 | 12,708,815 |
| 2019-12-02 | Phillips Charles G Iii | Sale | 6,145 | 88.11 | 541,448 |
| 2019-11-25 | Danziger Asaf (Chief Executive Officer) | Sale | 103,000 | 95.00 | 9,785,000 |
| 2019-11-25 | Danziger Asaf (Chief Executive Officer) | Option Ex | 103,000 | 22.00 | 2,266,000 |
| 2019-11-25 | Leung Gabriel | Sale | 20,000 | 95.00 | 1,900,000 |
| 2019-11-25 | Leung Gabriel | Option Ex | 20,000 | 7.03 | 140,600 |
| 2019-11-25 | Doyle William F (Executive Chairman) | Sale | 16,223 | 96.04 | 1,558,056 |
| 2019-11-20 | Leung Gabriel | Sale | 20,000 | 90.00 | 1,800,000 |
| 2019-11-20 | Leung Gabriel | Option Ex | 20,000 | 7.03 | 140,600 |
| 2019-11-20 | Doyle William F (Executive Chairman) | Sale | 150,000 | 90.68 | 13,602,450 |
| 2019-11-18 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Sale | 5,832 | 86.12 | 502,251 |
| 2019-11-18 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Option Ex | 5,832 | 3.44 | 20,062 |
| 2019-11-18 | Leung Gabriel | Sale | 10,000 | 85.00 | 850,000 |
| 2019-11-18 | Leung Gabriel | Option Ex | 10,000 | 7.03 | 70,300 |
| 2019-11-15 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Sale | 20,000 | 83.35 | 1,667,060 |
| 2019-11-15 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Option Ex | 20,000 | 3.44 | 68,800 |
| 2019-11-15 | Leung Gabriel | Sale | 10,000 | 83.35 | 833,510 |
| 2019-11-15 | Leung Gabriel | Option Ex | 10,000 | 5.24 | 52,350 |
| 2019-11-14 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Sale | 27,576 | 81.69 | 2,252,655 |
| 2019-11-14 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Option Ex | 27,576 | 4.64 | 127,869 |
| 2019-11-13 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Sale | 40,000 | 80.96 | 3,238,320 |
| 2019-11-13 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Option Ex | 40,000 | 4.64 | 185,479 |
| 2019-11-12 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Sale | 40,000 | 80.17 | 3,206,600 |
| 2019-11-12 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Option Ex | 40,000 | 4.64 | 185,479 |
| 2019-11-12 | Doyle William F (Executive Chairman) | Sale | 13,218 | 81.87 | 1,082,104 |
| 2019-11-11 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Sale | 8,600 | 80.14 | 689,161 |
| 2019-11-11 | Groenhuysen Wilhelmus Cm (Chief Financial Officer) | Option Ex | 8,600 | 4.64 | 39,878 |
| 2019-11-11 | Doyle William F (Executive Chairman) | Sale | 29,782 | 80.11 | 2,385,776 |
| 2019-11-04 | Ambrogi Michael J. (Chief Operating Officer) | Sale | 80,819 | 79.00 | 6,384,701 |
| 2019-11-04 | Ambrogi Michael J. (Chief Operating Officer) | Option Ex | 80,819 | 19.17 | 1,549,542 |
| 2019-10-24 | Shah Pritesh (Chief Commercial Officer) | Option Ex | 4,580 | 7.48 | 34,258 |
Insider trading activities including stock purchases, stock sales, and option exercises of NVCR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Novocure Ltd (symbol NVCR, CIK number 1645113) see the Securities and Exchange Commission (SEC) website.